The Veeda Newsletter


Advair generics and acquisitions to hit GSK in 2019

This is part of a root-and-branch renewal across the business, with a vision of a pharma-focused, oncology and immunology led company emerging.
Read more :

Aurobindo acquires Apotex's businesses in 5 European countries

Aurobindo Pharma on Monday said it had completed the acquisition of Canadian generic pharma firm Apotex’s commercial operations and certain supporting infrastructure in five European countries.
Read more :

Samsung Bioepis inks biosimilar deals to enter China

C-Bridge will establish a new company, AffaMed Therapeutics, under terms of the deal, and will license multiple biosimilar candidates from Samsung Bioepis to commercialize in China.
Read more :

Cipla acquires Wellthy stake to bring digital therapeutics to India

Drugmaker Cipla is to acquire an 11.7% stake in digital therapeutics company Wellthy Therapeutics.
Read more :

5 Top Drug/Biotech Merger & Acquisition Targets for 2019

As far as M&A activity in the biotech/drug sector is concerned, 2018 started with a bang with expectations of record breaking activity in the year. The new tax reforms left more cash in the hands of drug/biotech companies that could be invested for M&A activity.
Read more :
Contact Us